Area of research
Immunology · Physiology
Research interest
Research interests include Mast cells and histamine, Asthma and respiratory diseases, Acute Myeloid Leukemia Research, and Eosinophilic Disorders and Syndromes.
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of <i>PDGFRA</i>, <i>PDGFRB</i>, or <i>FGFR1</i> or With <i>PCM1-JAK2</i>
Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions
Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders
Reactive Eosinophil Proliferations in Tissue and the Lymphocytic Variant of Hypereosinophilic Syndrome
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis
Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions
Proposed Terminology and Classification of Pre-Malignant Neoplastic Conditions: A Consensus Proposal
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis
Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis